Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-16

Clinical Trial Update: Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update examining how food and an oral antacid influence BIIB021 pharmacokinetics and safety in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BIIB021 (BIIB021)

Snippet

Sponsor: Biogen | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED